An interventional study of Focal muscle vibration and NO Focal muscle vibration in Vibration Therapy, Healthy Volunteer Study and Hypoactivity, sponsored by Centre Hospitalier Universitaire de Saint Etienne. Recruiting at 1 site in France. Open to participants aged 19 Years to 45 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-05-26.
Sponsored by Centre Hospitalier Universitaire de Saint Etienne · Not applicable, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 56 studies in Sedentary Behavior with a site in France — 25 open to participants now, 27 under way, none of them phase 3. Sedentary Behavior · France.
Among the 56 studies in Sedentary Behavior with a site in France, this one is the 28th largest by planned enrollment of the 39 interventional ones that give a count, is one of 11 that started in 2025, is one of 39 with no phase, reaches primary completion later than 20 of the 26 other live ones, and was the 43rd registered.
1,276 studies on the registry are indexed under Sedentary Behavior; 292 are open to participants now.
Browse Sedentary Behavior studies →25 of the 56 studies in Sedentary Behavior with a site in France are open now. Recruiting first, the newest first:
Universite du Littoral Cote d'Opale · Sites in France
Ages 20–80 · Healthy volunteers
Centre Hospitalier Universitaire de Saint Etienne · Sites in France
Ages 25–50 · Healthy volunteers
University Hospital, Angers · Sites in France
Ages 18+
Université de Reims Champagne-Ardenne · Sites in France
Ages 18+
University Hospital, Clermont-Ferrand · Sites in France
Healthy volunteers
A study can be open while its sites in France have not opened yet or have stopped. Only those recruiting at a site in France →
Of the 184 Sedentary Behavior studies recruiting now, 77 (42%) set no upper age limit and 82 (45%) stop at 75 or younger; 30 take children under 18; 97 take healthy volunteers.
This study: 19 Years to 45 Years · all sexes · healthy volunteers too.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
56 studies; the count open now beside each. This study's row is marked.
First in 2006; this study’s year is marked. 11 started in 2025.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 42 is below the median of 60 across 1,077 interventional studies indexed under Sedentary Behavior.
Median enrollment 66 across the 39 interventional studies, 270 across the 17 observational. Of the 29 that completed or were terminated, 0 (0%) have results posted.
This tab as a report to print or save as PDF → With an account.
1 of 56 have an industry lead sponsor. The 10 most frequent:
Centre Hospitalier Universitaire de Saint Etienne is the lead sponsor of 598 studies on the registry; 128 are open to participants now.
Centre Hospitalier Universitaire de Saint Etienne has 8 studies filed under Sedentary Behavior — fewer than ten, so there is no comparison to draw.
9 of the studies in Sedentary Behavior with a site in France that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT05641116Centre Hospitalier Universitaire de Saint EtienneEffectiveness of an Intervention Combining Adapted Physical Activity and Therapeutic Education in Patients With Chronic Symptoms Attributed to Lyme Borreliosis. | 2026-12 |
| NCT06678906University Hospital, GrenoblePhysical Inactivity and Sedentary Behavior: Screening and Intervention in Ambulatory Primary Care | 2027-01 |
| NCT05931406University Hospital, Clermont-FerrandEffects of a Sedentary Behaviors at Work on Health in Emergency Medical Dispatchers and CODIS Operators (SECODIS) | 2027-03 |
| NCT07811115University of AvignonAssociations Between Physical Activity and Sedentary Behavior Profiles and Carotid Intima-media Thickness in Adolescents With Obesity | 2027-03 |
| NCT06274268Centre Hospitalier Metropole SavoieEffect of Sarcopenia on the Occurrence of Toxicity Related to Anti-cancer Treatments | 2027-05-01 |
Add all 9 to your calendar (.ics) → With an account.
Among the 56 studies in Sedentary Behavior with a site in France, from their registry updates:
This tab as a report to print or save as PDF → With an account.
Muscle deconditioning, characterized by a loss of muscle mass and strength, is a frequent consequence of prolonged lower limb unloading. Beyond muscle mass loss, reduced neural drive contributes significantly to strength decline, highlighting the need for interventions targeting neuromuscular function during immobilization. Focal muscle vibration (FMV) has shown promise in modulating neuromuscular excitability by activating muscle spindle afferents and inducing cortical adaptations. Chronic use of FMV has been associated with significant strength gains and improved neural command. This makes FMV an effective rehabilitation tool. Its simplicity and non-invasiveness further make it a practical countermeasure.
This study hypothesizes that a 10-day FMV protocol can induce neural adaptations to limit strength loss during unilateral lower limb suspension, offering a novel strategy against neuromuscular function decline.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.
What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Anti-inflammatory medicines such as prednisone, prednisolone and dexamethasone — not the anabolic steroids used for muscle.
Studies differ in what they allow: check which steroid medicines, routes (tablets, injections, creams, inhalers, eye drops) and doses this study accepts.
BMI (body mass index)
Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.
What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Corticosteroids (steroids)
Anti-inflammatory medicines such as prednisone, prednisolone and dexamethasone — not the anabolic steroids used for muscle.
Studies differ in what they allow: check which steroid medicines, routes (tablets, injections, creams, inhalers, eye drops) and doses this study accepts.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Participants will benefit a local vibration countermeasure program for the knee extensor muscles.
Device: Focal muscle vibration
the control group WILL not receive this countermeasure.
Device: NO Focal muscle vibration
focal muscle vibration sessions, using small and portable vibrator devices.
The control group will not receive any intervention.
Isometric force measurement
Maximal isometric force (% decrease) in knee extension of the immobilized leg will be evaluated
Time frame: Day 1, 7, 14, 28, 33
Maximum voluntary force measurement
Maximum voluntary force (Nm) in knee extension, assessed in isometric (for the immobilized leg and also for the contralateral leg), concentric (+60°/s and +180°/s) and eccentric (-60°/s) conditions.
Time frame: Day 1, 7, 14, 28, 33
Jumping performance measurement
Jumping performance (height, in cm), assessed in vertical jump tests (Squat Jump and Counter Movement Jump).
Time frame: Day 1, 7, 14, 28, 33
Postural balance measurement
Postural balance performance (displacement of center of pressure, in mm), assessed in a unipodal postural balance test performed on a strength platform
Time frame: Day 1, 7, 14, 28, 33
Neuromuscular fatigue measurement
Neuromuscular fatigue (decrease in maximum voluntary force (in %), assessed during a fatigue protocol consisting of quadriceps muscle contractions at incremental force levels.
Time frame: Day 1, 7, 14, 28, 33
Force-velocity-endurance measurement
Force-velocity-endurance profile, assessed during an effort performed on a cycloergometer at linearly decreasing power values.
Time frame: Day 1, 7, 14, 28, 33
Voluntary activation level evaluation
Voluntary activation level (in %), determined by the force increment obtained following stimulation during a maximal voluntary isometric contraction.
Time frame: Day 1, 7, 14, 28, 33
Cortico-spinal excitability measurement
Cortico-spinal excitability, assessed by electromyographic responses (motor evoked potentials, in mV) evoked by transcranial magnetic stimulation (TMS).
Time frame: Day 1, 7, 14, 28, 33
Spinal excitability evaluation
Spinal excitability (i.e. spinal reflexes, in mV), assessed by recording EMG responses evoked by electrical stimulation of the lumbar vertebrae.
Time frame: Day 1, 7,14 , 28, 33
Cortical activation of sensorimotor areas measurement
Cortical activation of sensorimotor areas, assessed by recording the electroencephalographic (EEG) signal during submaximal isometric contractions.
Time frame: Day 1, 7, 14, 28, 33
Muscle volume measurement
Muscle volume will be assessed by ultrasound of the thigh muscles (in cm2).
Time frame: Day 1, 7, 14, 28, 33
Determination of plasma molecular markers of bone and muscle remodeling
Assessment of blood factors of nerve (BDNF) and muscle remodeling (circulating steroids, insulin, GH, IGF-1, myostatin, activinA, follistatin).
Time frame: Day 1, 7, 14, 28, 33
Determination of plasma molecular markers of bone and muscle remodeling
Evaluation of bone remodeling factors by bAP, CTx, P1NP and Trap5b assays
Time frame: Day 1, 7, 14, 28, 33
Plasma molecular markers of thrombotic risk evaluation
Plasma molecular markers of thrombotic risk will be assessed by blood sampling followed by assay of HSP47 and D-dimer factors.
Time frame: Day 1, 7, 14, 28, 33
Plan to share: No
No publications or documents are linked to this record.
Started Jun 2025 (actual). Primary completion is estimated for Jun 2027, 23 months after the start.
Of 736 non-industry interventional studies with no phase under Sedentary Behavior, half reached primary completion within 14 months of starting (the median), counting those still running; a quarter within 6 and three quarters within 30. This study's planned 23 months is above that.
Counting every sponsor, half of 744 studies reached it within 14 months; a quarter within 6 and three quarters within 30.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Centre Hospitalier Universitaire de Saint Etienne →